Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Aclaris Therapeutics Inc buy melinda

Start price
€5.60
19.01.19 / 50%
Target price
€8.12
30.10.19
Performance (%)
-70.19%
End price
€1.67
30.10.19
Summary
This prediction ended on 30.10.19 with a price of €1.67. The BUY prediction by melinda for Aclaris Therapeutics Inc performed very badly with a performance of -70.19%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Aclaris Therapeutics Inc -0.780% -0.780% -86.293% -94.802%
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to melinda what are the pros and cons of Aclaris Therapeutics Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Aclaris Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -70.19%
Target price 8.118
Change
Ends at 30.10.19

Secteur Recherche biotechnologique et médicale Agenda 27/02 | 16:30 Présentation



    métier
Aclaris Therapeutics, Inc. est une société biopharmaceutique dirigée par des dermatologues. Société se concentrant sur le développement et la commercialisation de médicaments différenciés pour le traitement des indications dermatologiques. La Société se concentre également sur la découverte et le développement d'inhibiteurs de kinases pour le traitement des troubles inflammatoires et immunologiques et du cancer. La technologie Kinect de la plateforme de découverte de médicaments de La Société is a Moteur de Découverte de Médicaments Axé sur les kinases Qui utilisent la CHIMIE computationnelle verser integrer des collections de compounds Exclusifs AINSI Qué des Biologistes et des chimistes Médicaux très expérience identifiant répandrai et faire Progression des candidats potentiels vers le développement préclinique et clinique.

Nombre d'employés : 96 personnes.

Prediction Buy
Perf. (%) -70.19%
Target price 8.118
Change
Ends at 30.10.19

Buy closed

Stopped prediction by melinda for Aclaris Therapeutics Inc

buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€5.05
06.11.23
€6.00
06.11.24
-81.19%
10.12.23

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€11.54
21.02.22
€15.00
21.02.23
2.90%
22.02.23

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€1.43
23.06.20
€1.60
04.11.21
913.99%
05.11.21

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€14.25
17.08.18
€18.31
03.12.18
-40.25%
03.12.18

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€18.73
04.02.18
€20.57
26.03.18
-18.15%
26.03.18

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€23.91
04.10.17
€27.06
19.12.17
-9.54%
19.12.17

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€29.29
07.03.17
€30.67
07.09.17
-18.57%
07.09.17

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€25.29
21.02.17
€27.06
24.02.17
7.13%
24.02.17

Could be worthwhile Investment >10% per year
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€18.34
10.07.16
€19.84
29.08.16
8.36%
29.08.16

Could be worthwhile Investment >10% per year